Calculated remnant cholesterol and 7-day severe adverse events after carotid revascularization: A retrospective cohort study.

Authors

Muyuan Li, Shuaiwei Guo, Kai Wang, Ruhan Yi, Xiao Zhang, Xiaoxin He, Xuebing Feng, Xia Lu, Zhengyu Wang, Renjie Yang, Fei Chen, Peng Gao, Liqun Jiao

Published in

Nutrition, metabolism, and cardiovascular diseases : NMCD. Pages 104960. Aug 14, 2026. Epub Aug 14, 2026.

Abstract

Remnant cholesterol (RC), calculated from routine lipid measurements, has been associated with atherosclerotic vascular disease, but its relationship with early severe adverse events (SAEs) after carotid revascularization remains uncertain. We examined the association between calculated preoperative RC and 7-day SAE after carotid endarterectomy or carotid artery stenting.
This single-center retrospective cohort included 3361 consecutive patients undergoing carotid revascularization between January 2017 and July 2023. RC was calculated as total cholesterol minus low-density lipoprotein cholesterol minus high-density lipoprotein cholesterol. The primary outcome was a composite of ischemic stroke, hemorrhagic stroke, myocardial infarction, seizure, unplanned reoperation, or death within 7 days. Multivariable logistic regression modeled RC per 10-mg/dL increase. Seventy patients (2.1%) experienced a 7-day SAE. Each 10-mg/dL increase in RC was associated with higher adjusted odds of 7-day SAE (adjusted odds ratio, 1.325; 95% confidence interval, 1.206-1.456; P < 0.001). The association was consistent across prespecified RC-outlier, sparse-event, and adjustment-set sensitivity analyses. Restricted cubic spline analysis supported an overall association, although apparent nonlinearity was concentrated in the sparse upper tail and attenuated after outlier handling. In exploratory component analysis, the association was most evident for ischemic stroke.
Higher calculated preoperative RC was associated with higher adjusted odds of 7-day SAE after carotid revascularization. RC may provide complementary lipid-related information for perioperative assessment, but external validation is required before clinical implementation.

PMID:
42705982
Bibliographic data and abstract were imported from PubMed on 08 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.